Guardant Health Inc

Common Name
Guardant Health
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
1,999
Ticker
GH
Exchange
NASDAQ/NGS
Description
Guardant Health Inc. is an innovative biotechnology company specializing in the development and commercialization of precision oncology diagnostics. This company is recognized for its groundbreaking w...

Guardant Health's GHG Emissions Data Preview

In 2023, Guardant Health completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Guardant Health has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Guardant Health's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Guardant Health’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Guardant Health’s data sources below and access millions more through our Disclosure Search.

a. Guardant Health's Corporate Responsibility Report (CRR) 2025
Trace every data point back to Guardant Health’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Guardant Health's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Guardant Health amounted to 4,222 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Guardant Health's Scope 1 Emissions Over Time

202304509001.35 k1.8 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Guardant Health's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Guardant Health were 1,659 metric tons of CO₂ equivalent (tCO₂e). a

What are Guardant Health's Scope 2 emissions?

In 2023, Guardant Health reported Scope 2 greenhouse gas (GHG) emissions of 2,563 tCO₂e without specifying the calculation method. a

What methodology does Guardant Health use for Scope 2 reporting?

In 2023, Guardant Health reported its Scope 2 emissions using an unspecified methodology. a

Guardant Health's Scope 2 Emissions Over Time

202306501.3 k1.95 k2.6 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Guardant Health’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Guardant Health reported Scope 1 greenhouse gas (GHG) emissions of 1,659 tCO₂e and total revenues of USD 564 millions. This translates into an emissions intensity of 2.94 tCO₂e per millions USD. a

Guardant Health's Scope 1 Emissions Intensity Compared to Peers

1001,00010,000100,0001,000,000Scope 1 Emissions (tCO2e)1005002,00020,000100,000Revenues (Millions of USD)RIQVIA HoldingsYear: 2023Scope 1: 8,221 tCO2eRevenue: $M 14,983Scope 1 Intensity: 0.55 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MLegend BiotechYear: 2023Scope 1: 770 tCO2eRevenue: $M 285Scope 1 Intensity: 2.70 tCO2e/$MExact SciencesYear: 2023Scope 1: 12,177 tCO2eRevenue: $M 2,500Scope 1 Intensity: 4.87 tCO2e/$MDanaherYear: 2024Scope 1: 109,046 tCO2eRevenue: $M 23,875Scope 1 Intensity: 4.57 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MGlaukosYear: 2023Scope 1: 575 tCO2eRevenue: $M 315Scope 1 Intensity: 1.83 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MAgilent TechnologiesYear: 2023Scope 1: 20,460 tCO2eRevenue: $M 6,833Scope 1 Intensity: 2.99 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MQuest DiagnosticsYear: 2021Scope 1: 238,910 tCO2eRevenue: $M 10,788Scope 1 Intensity: 22.15 tCO2e/$MWatersYear: 2022Scope 1: 15,600 tCO2eRevenue: $M 2,972Scope 1 Intensity: 5.25 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MThermo Fisher ScientificYear: 2024Scope 1: 315,843 tCO2eRevenue: $M 42,879Scope 1 Intensity: 7.37 tCO2e/$MRRRevvityYear: 2023Scope 1: 2,121 tCO2eRevenue: $M 2,751Scope 1 Intensity: 0.77 tCO2e/$MCharles River LaboratoriesYear: 2023Scope 1: 85,957 tCO2eRevenue: $M 4,129Scope 1 Intensity: 20.82 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MIDEXX LaboratoriesYear: 2023Scope 1: 16,458 tCO2eRevenue: $M 3,661Scope 1 Intensity: 4.50 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MNateraYear: 2024Scope 1: 5,143 tCO2eRevenue: $M 1,697Scope 1 Intensity: 3.03 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$M

How does Guardant Health's GHG emissions intensity compare to its peers?

In 2023, Guardant Health reported a Scope 1 emissions intensity of 2.94 tCO₂e per millions USD. Compared to the peer group median of 4.01, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Guardant Health rank on GHG emissions intensity within its industry?

In 2023, Guardant Health ranked 9 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Guardant Health is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Guardant Health's GHG Emissions Dataset?
Sign Up